1. HOME

What are small molecules?

The small molecule market, which accounts for two-thirds of the global pharmaceutical market, is worth approximately 1,460 billion USD. Celltrion is successfully conducting various global chemical projects to become a key leader of the global pharmaceutical market.

Business Capabilities

World-class development, clinical trials and regulatory approval know-hows
  • World-class development, clinical and approval capabilities accumulated during the biosimilar commercialization process
  • Synergy from collaboration with affiliates specializing in chemical medicine production

Business Capabilities

Production and quality control capabilities recognized by leading regulators
  • Korea's first production facility to be certified by the US FDA and the UK MHRA
  • Capable of manufacturing 5 billion tablets per year
  • Operates a stable SCM encompassing production and distribution

Business Capabilities

Equipped with chemical drug specialized R&D facility
  • Continuous development of new, synthetic and generic drug pipeline
  • Research platform technologies such as drug delivery systems through specialized affiliates
  • Optimize production processes and research treatment methods in line with biopharmaceuticals